Perfil
Tuvia Gilat is the founder of Galmed Pharmaceuticals Ltd. which was founded in 2000.
Currently, he is the Scientific Director at Galmed Medical Research Ltd. Dr. Gilat's former positions include Director at BioCancell Therapeutics, Inc. and Director at Tel-Aviv Sourasky Medical Center where he served as Director from 1965 to 1996.
Dr. Gilat holds a doctorate degree from The Hebrew University of Jerusalem.
Cargos activos de Tuvia Gilat
| Empresas | Cargo | Inicio |
|---|---|---|
Galmed Medical Research Ltd. | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Tuvia Gilat.
| Empresas | Cargo | Fin |
|---|---|---|
Tel-Aviv Sourasky Medical Center
Tel-Aviv Sourasky Medical Center Hospital/Nursing ManagementHealth Services Operates as healthcare treatment and research institutions for charity | Director/Miembro de la Junta | 01/01/1996 |
| GALMED PHARMACEUTICALS LTD. | Fundador | - |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology Is a biopharmaceuticals company | Director/Miembro de la Junta | - |
Formación de Tuvia Gilat.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology Is a biopharmaceuticals company | Health Technology |
Tel-Aviv Sourasky Medical Center
Tel-Aviv Sourasky Medical Center Hospital/Nursing ManagementHealth Services Operates as healthcare treatment and research institutions for charity | Health Services |
Galmed Medical Research Ltd. | |
Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures aramchol for non-alcoholic steatohepatitis | Health Technology |
- Bolsa de valores
- Insiders
- Tuvia Gilat
















